IBA Molecular
Pharmaceutical ManufacturingCommunity of Madrid, Spain51-200 Employees
IBA Molecular North America, Inc. (IBAMNA) is a leading developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging in the U.S. The company’s expertise in radiolabelling services and scalable manufacturing from pre-clinical to full commercial production is helping broaden the impact of nuclear medicine and molecular imaging/therapy. IBAMNA’s parent company is Illinois Health and Science (IHS), a non-profit healthcare system that also owns Decatur (IL) Memorial Hospital, Integrated Health Network and Zevacor Molecular. Zevacor Molecular and IBAMNA, as affiliated radiopharmaceutical manufacturers, are committed to the IHS mission of enhancing the span, experience and quality of human life through improved patient care and outcomes. IBA Molecular North America, Inc. (IBAMNA), a U.S. leader in the manufacture and distribution of radiopharmaceuticals, announced that as of January 1, 2016, it will do business as Zevacor Pharma, Inc. (Zevacor Pharma). The decision to rebrand the company reflects a refined vision for the future of the firm as well as its close relationship with Zevacor Molecular. Both IBAMNA and Zevacor Molecular are owned by Illinois Health and Science (IHS). For more information, please visit www.ibamolecular.com
1-888-653-2347 
support@leadiq.com 
